Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 5.46
(-0.36%)
CNY 5.46
(-0.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 644.62 Million CNY | -9.31% |
| 2022 | 710.76 Million CNY | -11.14% |
| 2021 | 799.83 Million CNY | -12.99% |
| 2020 | 919.22 Million CNY | 59.85% |
| 2019 | 575.06 Million CNY | 4.56% |
| 2018 | 549.96 Million CNY | 0.06% |
| 2017 | 549.65 Million CNY | 6.29% |
| 2016 | 517.1 Million CNY | -5.18% |
| 2015 | 545.34 Million CNY | 18.09% |
| 2014 | 461.79 Million CNY | 16.4% |
| 2013 | 396.73 Million CNY | 30.47% |
| 2012 | 304.08 Million CNY | 21.81% |
| 2011 | 249.63 Million CNY | 50.51% |
| 2010 | 165.86 Million CNY | 17.81% |
| 2009 | 140.79 Million CNY | 36.1% |
| 2008 | 103.44 Million CNY | 43.04% |
| 2007 | 72.32 Million CNY | 63.91% |
| 2006 | 44.12 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 150.32 Million CNY | 6.5% |
| 2024 Q1 | 141.15 Million CNY | -18.04% |
| 2024 Q3 | 128.3 Million CNY | -14.65% |
| 2023 Q4 | 172.22 Million CNY | 12.83% |
| 2023 Q3 | 152.63 Million CNY | -5.31% |
| 2023 Q2 | 161.19 Million CNY | 1.66% |
| 2023 FY | 644.62 Million CNY | -9.31% |
| 2023 Q1 | 158.56 Million CNY | -12.5% |
| 2022 Q1 | 179.55 Million CNY | -14.57% |
| 2022 FY | 710.76 Million CNY | -11.14% |
| 2022 Q4 | 181.21 Million CNY | 2.31% |
| 2022 Q3 | 177.11 Million CNY | 2.45% |
| 2022 Q2 | 172.87 Million CNY | -3.72% |
| 2021 Q2 | 185.67 Million CNY | -19.47% |
| 2021 Q1 | 230.57 Million CNY | -22.24% |
| 2021 Q3 | 173.41 Million CNY | -6.6% |
| 2021 FY | 799.83 Million CNY | -12.99% |
| 2021 Q4 | 210.17 Million CNY | 21.19% |
| 2020 Q3 | 220.87 Million CNY | -13.19% |
| 2020 Q2 | 254.42 Million CNY | 72.61% |
| 2020 Q1 | 147.39 Million CNY | -10.3% |
| 2020 FY | 919.22 Million CNY | 59.85% |
| 2020 Q4 | 296.53 Million CNY | 34.25% |
| 2019 Q2 | 148.35 Million CNY | 33.68% |
| 2019 FY | 575.06 Million CNY | 4.56% |
| 2019 Q1 | 110.98 Million CNY | -29.43% |
| 2019 Q3 | 151.39 Million CNY | 2.05% |
| 2019 Q4 | 164.32 Million CNY | 8.54% |
| 2018 Q4 | 157.27 Million CNY | 17.74% |
| 2018 Q1 | 124 Million CNY | -28.62% |
| 2018 FY | 549.96 Million CNY | 0.06% |
| 2018 Q3 | 133.57 Million CNY | -1.13% |
| 2018 Q2 | 135.1 Million CNY | 8.95% |
| 2017 Q2 | 125.5 Million CNY | 14.63% |
| 2017 FY | 549.65 Million CNY | 6.29% |
| 2017 Q4 | 173.72 Million CNY | 23.27% |
| 2017 Q3 | 140.92 Million CNY | 12.29% |
| 2017 Q1 | 109.49 Million CNY | -30.78% |
| 2016 Q4 | 158.16 Million CNY | 17.28% |
| 2016 Q1 | 105.34 Million CNY | -40.38% |
| 2016 FY | 517.1 Million CNY | -5.18% |
| 2016 Q2 | 118.72 Million CNY | 12.71% |
| 2016 Q3 | 134.86 Million CNY | 13.59% |
| 2015 Q2 | 138.52 Million CNY | 49.1% |
| 2015 Q4 | 176.68 Million CNY | 28.75% |
| 2015 Q3 | 137.22 Million CNY | -0.94% |
| 2015 FY | 545.34 Million CNY | 18.09% |
| 2015 Q1 | 92.9 Million CNY | -35.15% |
| 2014 Q1 | 78.5 Million CNY | -45.51% |
| 2014 Q2 | 117.03 Million CNY | 49.08% |
| 2014 Q3 | 123 Million CNY | 5.1% |
| 2014 Q4 | 143.25 Million CNY | 16.47% |
| 2014 FY | 461.79 Million CNY | 16.4% |
| 2013 Q3 | 100.14 Million CNY | 16.25% |
| 2013 Q1 | 66.37 Million CNY | -32.31% |
| 2013 Q2 | 86.15 Million CNY | 29.79% |
| 2013 FY | 396.73 Million CNY | 30.47% |
| 2013 Q4 | 144.06 Million CNY | 43.85% |
| 2012 Q1 | 57.31 Million CNY | -30.33% |
| 2012 Q2 | 71.61 Million CNY | 24.95% |
| 2012 Q3 | 77.1 Million CNY | 7.67% |
| 2012 Q4 | 98.05 Million CNY | 27.17% |
| 2012 FY | 304.08 Million CNY | 21.81% |
| 2011 FY | 249.63 Million CNY | 50.51% |
| 2011 Q1 | 37.66 Million CNY | -33.21% |
| 2011 Q2 | 60.41 Million CNY | 60.43% |
| 2011 Q3 | 69.29 Million CNY | 14.68% |
| 2011 Q4 | 82.26 Million CNY | 18.73% |
| 2010 Q3 | 46.29 Million CNY | 14.08% |
| 2010 Q2 | 40.57 Million CNY | 79.49% |
| 2010 Q1 | 22.6 Million CNY | -45.54% |
| 2010 Q4 | 56.38 Million CNY | 21.8% |
| 2010 FY | 165.86 Million CNY | 17.81% |
| 2009 Q1 | 22.1 Million CNY | -25.12% |
| 2009 Q3 | 37.08 Million CNY | -7.51% |
| 2009 Q4 | 41.51 Million CNY | 11.94% |
| 2009 FY | 140.79 Million CNY | 36.1% |
| 2009 Q2 | 40.09 Million CNY | 81.38% |
| 2008 Q3 | 28.51 Million CNY | 0.0% |
| 2008 Q4 | 29.51 Million CNY | 3.53% |
| 2008 FY | 103.44 Million CNY | 43.04% |
| 2007 FY | 72.32 Million CNY | 63.91% |
| 2006 FY | 44.12 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 7.89 Billion CNY | 91.83% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3.36 Billion CNY | 80.845% |
| Blue Sail Medical Co.,Ltd. | 4.92 Billion CNY | 86.917% |
| Andon Health Co., Ltd. | 3.18 Billion CNY | 79.769% |
| Allmed Medical Products Co., Ltd | 2.75 Billion CNY | 76.616% |
| Tofflon Science and Technology Group Co., Ltd. | 5.64 Billion CNY | 88.574% |
| Truking Technology Limited | 6.8 Billion CNY | 90.526% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 1.3 Billion CNY | 50.416% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 1.46 Billion CNY | 56.076% |
| Autek China Inc. | 1.73 Billion CNY | 62.892% |
| Intco Medical Technology Co., Ltd. | 6.91 Billion CNY | 90.683% |
| Jiangsu Apon Medical Technology Co., Ltd. | 417.98 Million CNY | -54.222% |
| Winner Medical Co., Ltd. | 8.18 Billion CNY | 92.124% |
| Imeik Technology Development Co.,Ltd. | 2.85 Billion CNY | 77.413% |
| Zhonghong Pulin Medical Products Co., Ltd. | 2.1 Billion CNY | 69.38% |
| Caina Technology Co., Ltd. | 410.47 Million CNY | -57.044% |